Home LiteratureArticle Details
PMID: 33622881 Published · ppublish English

Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.

In vivo (Athens, Greece) ·Vol. 35 ·No. 2 ·2021-00-00

Friedrich RE, Tuzcu CT

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant tumour predisposition syndrome that can cause plexiform neurofibromas (PNFs). This study examines the surgical procedures that have been performed on large PNFs of the lower extremities. Surgical procedures on the lower extremity performed on 90 patients with NF1 with PNFs were evaluated. The topography of the tumours was classified according to dermatomes and functional units. A total of 243 surgical interventions on the regions of interest were performed. Neurological complications were rarely noted and usually occurred temporarily. There was no preference for dermatomes affected by PNF. The proportion of patients with malignant peripheral nerve sheath tumours (MPNSTs) in this group was 4/90 (4.4%). PNFs often require repeated local interventions to achieve the treatment goal. Local tumour recurrences are to be expected even after extensive tumour reduction. Rapid tumour growth combined with new pain sensations can be signs of a MPNST.

Keywords
MPNST Neurofibromatosis type 1 buttocks – surgery foot – surgery lower extremity – surgery peripheral nerve sheath tumour plexiform neurofibroma
MeSH 主题词
Buttocks/surgery Humans Leg Nerve Sheath Neoplasms/diagnosis,surgery Neurofibroma, Plexiform Neurofibromatosis 1/complications,diagnosis,surgery
Article Info
Journal
In vivo (Athens, Greece)
Abbr.
In Vivo
ISSN
1791-7549
Corresponding email
Published
2021-00-00
Language
English
Country/Region
Greece
NLM ID
8806809
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com